Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19
Vidisha Singh, Veronica Obregon-Perko, Stacey A. Lapp, Anna Marie Horner, Alyssa Brooks, Lisa Macoy, Laila Hussaini, Austin Lu, Theda Gibson, Guido Silvestri, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Evan J. Anderson, Christina A. Rostad, Ann Chahroudi
Vidisha Singh, Veronica Obregon-Perko, Stacey A. Lapp, Anna Marie Horner, Alyssa Brooks, Lisa Macoy, Laila Hussaini, Austin Lu, Theda Gibson, Guido Silvestri, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Evan J. Anderson, Christina A. Rostad, Ann Chahroudi
View: Text | PDF
Research Article COVID-19

Limited induction of SARS-CoV-2–specific T cell responses in children with multisystem inflammatory syndrome compared with COVID-19

  • Text
  • PDF
Abstract

Why multisystem inflammatory syndrome in children (MIS-C) develops after SARS-CoV-2 infection in a subset of children is unknown. We hypothesized that aberrant virus–specific T cell responses contribute to MIS-C pathogenesis. We quantified SARS-CoV-2–reactive T cells, serologic responses against major viral proteins, and cytokine responses from plasma and peripheral blood mononuclear cells in children with convalescent COVID-19, in children with acute MIS-C, and in healthy controls. Children with MIS-C had significantly lower virus-specific CD4+ and CD8+ T cell responses to major SARS-CoV-2 antigens compared with children convalescing from COVID-19. Furthermore, T cell responses in participants with MIS-C were similar to or lower than those in healthy controls. Serologic responses against spike receptor binding domain (RBD), full-length spike, and nucleocapsid were similar among convalescent COVID-19 and MIS-C, suggesting functional B cell responses. Cytokine profiling demonstrated predominant Th1 polarization of CD4+ T cells from children with convalescent COVID-19 and MIS-C, although cytokine production was reduced in MIS-C. Our findings support a role for constrained induction of anti–SARS-CoV-2–specific T cells in the pathogenesis of MIS-C.

Authors

Vidisha Singh, Veronica Obregon-Perko, Stacey A. Lapp, Anna Marie Horner, Alyssa Brooks, Lisa Macoy, Laila Hussaini, Austin Lu, Theda Gibson, Guido Silvestri, Alba Grifoni, Daniela Weiskopf, Alessandro Sette, Evan J. Anderson, Christina A. Rostad, Ann Chahroudi

×

Figure 1

SARS-CoV-2–specific T cell responses.

Options: View larger image (or click on image) Download as PowerPoint
SARS-CoV-2–specific T cell responses.
(A–C) SARS-CoV-2 CD4+ T cell data ...
(A–C) SARS-CoV-2 CD4+ T cell data in MIS-C, convalescent COVID-19, and healthy children (HC) shown as AIM+ (OX40+41BB+) CD4+ T cells in response to CD4_S peptide MP (spike-containing) and CD4_R peptide MP (non-spike proteins) stimulation by (A) fold change (FC) over the DMSO condition, (B) frequency of CD4+OX40+41BB+ T cells after MP stimulation with DMSO subtraction, and (C) total (frequency of CD4_S plus CD4_R MP) CD4+ T cell responses with DMSO subtraction. (D–F) SARS-CoV-2 CD8+ T cell data in MIS-C, convalescent COVID-19, and HC shown as AIM+ (CD69+41BB+) CD8+ T cells in response to CD8-A peptide MP and CD8-B peptide MP stimulation by (D) FC over the DMSO condition, (E) frequency of CD8+CD69+41BB+ T cells after MP stimulation with DMSO subtraction, and (F) total (frequency of CD8-A plus CD8-B MP) CD8+ T cell responses with DMSO subtraction. DMSO, CD4_S, and CD8-A: MIS-C (n = 21), COVID-19 (n = 19), and HC (n = 20). CD4_R and CD8-B: MIS-C (n = 16), COVID-19 (n = 16), and HC (n = 20). Background-subtracted values ≤ 0 are represented as the lowest calculated AIM+ CD4+ or CD8+ T cell frequency in the data set. Geometric mean shown with statistical comparison by Kruskal-Wallis test. *P < 0.05, **P ≤ 0.01, ***P ≤ 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts